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Abstract The aim of this retrospective study was to
evaluate the prognostic signiWcance of paratracheal lymph
node dissection including hemithyroidectomy for the devel-
opment of hypo(para)thyroidism. From 1990 to 2004, 169
patients with a carcinoma of the larynx or hypopharynx
who underwent paratracheal lymph node dissection were
selected. Data of 137 patients (23 women, 114 men) were
analyzed. Hundred patients were tested on thyroid function.
Patient, tumor and treatment characteristics were noted
including age, gender, site, TNM stage and details of sur-
gery, radiotherapy and chemotherapy. Seventy percent of
the tested patients had hypothyroidism (36% clinical, 34%
subclinical); 33% had hypoparathyroidism. All patients
with hypo(para)thyroidism underwent various lymph node
treatment modalities. For the various treatment combina-
tions, no increase of hypo(para)thyroidism was found if a
bilateral paratracheal lymph node dissection was per-
formed. The incidence of hypo(para)thyroidism after laryn-
gectomy in combination with hemithyroidectomy, neck
dissection and paratracheal lymph node dissection is high.
An additional risk of paratracheal dissection for the devel-
opment of hypo(para)thyroidism could not be shown.
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Introduction
The incidence of endocrine dysfunction after treatment for
laryngeal and hypopharyngeal carcinoma is high, especially
after combination treatment of radiotherapy and surgery.
The incidence of hypothyroidism is between 10 and 78%,
depending on treatment modalities [1–3]. In our previous
cross-sectional study we found an incidence of hypothy-
roidism of 77% in patients after total laryngectomy, hemi-
thyroidectomy and radiotherapy. Risk factors for the
development of hypothyroidism were laryngectomy, hemi-
thyroidectomy and ipsilateral neck dissection [4].
Hypothyroidism causes symptoms such as weight gain,
cold intolerance, dry skin, constipation, depression, cogni-
tive impairment and a decrease in gastrointestinal tract
motility. These symptoms may have signiWcant impact on
the quality of life [5, 6].
Hypoparathyroidism is a rare condition and most com-
monly occurs because of damage or removal of (para)thy-
roid glands at the time of thyroid surgery [7, 8].
Hypoparathyroidism is estimated to occur in between 12
and 31% of cases with regard to laryngectomy combined
with hemithyroidectomy [7].
In advanced laryngeal and hypopharyngeal carcinoma
paratracheal lymph node (PTLN) dissection is frequently
performed [9]. The reported incidence of PTLN metastases
varies between 9 and 36% depending on the site and stage
of the primary tumor [10–13].
The vascular supply of the (remaining part of the) thy-
roid gland may be injured during PTLN dissection, which
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ism [14].
To our knowledge no studies reported the relationship
between PTLN dissection and development of hypothy-
roidism. The purpose of this study is to examine if PTLN
dissection is an additional risk factor for the development
of (para)thyroid function [4].
Patients and methods
A retrospective analysis was performed on 169 patients
who underwent laryngectomy and paratracheal lymph node
dissection because of primary or recurrent laryngeal or hyp-
opharyngeal carcinoma between 1990 and 2004. Thirty-two
patients who underwent total thyroidectomy were excluded.
In the remaining group of 137 patients thyroid function was
tested on indication only. Results were obtained from 100
patients.
Patient, tumor and treatment parameters were collected
including age, gender, site, TNM stage and details of sur-
gery, radiotherapy and chemotherapy. Thyroid function
was classiWed as euthyroidism (normal TSH, 0.3–4.5 mU/L)
and normal free T4 (11.0–24.0 pmol/L)), clinical hypo-
thyroidism (high TSH and low free T4) and subclinical
hypothyroidism (high TSH and normal free T4). Parathyroid
function was classiWed as normal if calcium serum levels
were between 2.20 and 2.60 mmol/L with a serum albumin
of 35–52 G/L. Corrected calcium levels were used.
Comparison contingency tables were made with Pearsons
2 for nominal data.
Results
Data of 23 females and 114 males were analyzed (shown in
Table 1). The mean age was 61.9 years. Fifty-Wve patients
died during follow-up. The primary tumors were located in
the supraglottis (n = 45), glottis (n = 64), subglottis (n = 1),
piriform sinus (n = 19) and posterior pharyngeal wall or
post-cricoid area (n = 8). One-hundred and seventeen
tumors were located unilaterally and 20 had a midline loca-
tion.
Tumor stage was T2, T3 and T4 in 3, 28 and 40 cases,
respectively, whereas 66 patients had a recurrence after
radiotherapy. Thirty-six patients were staged as a N0 neck.
Fifteen patients were classiWed with a N1 neck, 16 with N2,
4 with N3 and all 66 patients with a local recurrence with a
N0 neck.
All, but one patient underwent total laryngectomy. Hun-
dred and thirty-two patients underwent hemithyroidectomy.
Table 1 Patient, tumor and treatment characteristics associated with
hypothyroidism
TSH
< 4.5
% TSH
> 4.5
% Not 
tested
P
Sex
Male 28 33 56 67 30 0.096
Female 2 12 14 88 7
Age (years)
<60 8 20 32 80 10 0.032
61–70 13 33 28 67 20
>70 9 47 10 53 7
Site
Supraglottis 7 21 26 79 12 0.429
Glottis 19 37 32 63 13
Subglottis 0 0 1
Piriform sinus 3 27 8 73 8
Hypopharynx 1 20 4 80 3
Side
Left 12 32 26 68 17 0.409
Median 0 4 100 16
Right 18 31 40 69 4
Stage
T1 0 0 0 0.495
T2 0 0 3
T3 4 20 16 80 8
T4 11 35 20 65 9
Recurrence 15 31 34 69 17
N0 9 32 19 68 8 0.768
N1 4 36 7 64 4
N2 2 22 7 78 7
N3 0 3 100 1
N4 0 0 0
Recurrence 15 31 34 69 17
Laryngectomy
Total 30 30 70 70 36 1.00
Partial 0 0 1
Hemithyroidectomy
Yes 29 29 70 70 33 0.125
No 1 100 0 4
Neck dissection
Ipsilateral
Yes 18 27 49 73 23 0.330
No 12 36 21 64 14
Contralateral
Yes 10 26 28 74 11 0.529
No 20 32 42 68 26
Paratracheal dissection
Ipsilateral
Yes 30 30 70 70 37123
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neck dissection on the ipsilateral side and 49 patients a
bilateral neck dissection. All 137 patients underwent a para-
tracheal lymph node dissection of the ipsilateral side and 70
(51%) bilaterally. All patients except 9 received radiother-
apy; 67 patients received radiotherapy as primary treatment
(3 patients combined with chemotherapy) and 61 patients
received radiotherapy postoperatively.
Thirty-seven patients were not tested for hypothyroidism
(30 men, 7 women) during follow-up. The prevalence of
thyroid dysfunction was 70%. Thirty-six patients (36%)
had clinical hypothyroidism and 34 patients (34%) had sub-
clinical hypothyroidism. Thirty patients had normal labora-
tory results. Fourteen women (87.5%) and 56 men (66.7%)
had hypothyroidism.
Table 2 shows the incidence of hypothyroidism after
several combinations of paratracheal lymph node dissection
(ipsilateral or bilateral) and neck dissection (ipsilateral or
bilateral). In the PTLN dissection only group, consisting of
33 patients, 67% of the patients with unilateral PTLN dis-
section developed hypothyroidism versus 60% of the
patients with a bilateral PTLN dissection. In the ipsilateral
neck dissection group, consisting of 29 patients, these
Wgures were 83 and 33% and in the bilateral neck dissection
group, consisting of 38 patients, 70 and 75%, respectively.
The diVerences within these three groups consisted thus
in the bilateral paratracheal lymph node dissection. How-
ever, no statistical relevance in univariate and multivariate
studies was found.
Comparison contingency tables were made with Pear-
sons 2 for nominal data which showed no statistical sig-
niWcance for paratracheal lymph node dissection or any
other variable except for age (P = 0.003). Therefore, step-
wise logistic regression analysis was not done.
We found 43 patients (33%) with hypoparathyroidism.
Six of the patients tested for thyroid dysfunction were not
tested for hypoparathyroidism (Table 3). Thirty-six patients
developed hypoparathyroidism within 6 months after sur-
gery, mostly within 7 days postoperatively, 1 patient more
than 6 months after surgery and 6 patients more than 1 year
after surgery. Of the patients with hypoparathyroidism, 35
patients were tested for thyroid function as well. Seventy-
one percent had thyroid dysfunction (37% clinical hypothy-
roidism and 34% subclinical hypothyroidism). Patients
with bilateral PTLN dissection did not develop more often
hypoparathyroidism than patients with ipsilateral.
Discussion
In the present study the incidence of hypothyroidism after
laryngectomy with PTLN dissection was 70%. The inci-
dence of hypoparathyroidism was 33%. If it is considered
that patients who are not tested on indication did not have
hypo(para)thyroidism, the incidence of hypothyroidism and
hypoparathyroidism would be 51% (70 out of 137) and
31% (43 out of 137), respectively. However, our cross-
sectional study showed a high incidence of occult hypothy-
roidism [4]. On the other hand, if all patients who are not
tested would have had hypothyroidism and hypoparathy-
roidism, these Wgures would be 78% (107 out of 137) and
58% (80 out of 137). Therefore, it can be anticipated that if
all patients, who undergo total laryngectomy, hemithyroid-
ectomy, paratracheal lymph node dissection and radiother-
apy, were tested the incidences of hypothyroidism would be
somewhere between 51 and 78%. Only in a prospective
study in which all patients are routinely screened on
hypo(para)thyroidism will provide more precise Wgures. In
our previous cross-sectional study we found an incidence of
hypothyroidism of 77% in patients after total laryngectomy,
hemithyroidectomy and radiotherapy [4].
In our previous study no parathyroid dysfunction was
found [4]. Geminiani et al. [7] found no parathyroid dys-
function following laryngeal surgery while Thorp et al. [15]
found after surgery with or without radiotherapy an incidence
Table 1 continued
137 patients were included in our study of which 100 patients were
tested
TSH
< 4.5
% TSH
> 4.5
% Not 
tested
P
Contralateral
Yes 17 35 32 65 21 0.315
No 13 26 38 74 16
Radiotherapy
Yes 28 29 68 71 32 0.373
No 2 50 2 50 5
Chemotherapy
Yes 0 2 100 1 0.350
No 30 31 68 69 36
Table 2 The incidence of hypothyroidism after several lymph node
treatment modalities [paratracheal lymph node dissection (PTLN) and/
or neck dissection (ND)]
PTLN paratracheal lymph node dissection, ND modiWed radical neck
dissection or selective neck dissection, HT hypothyroidism
ND PTLN TSH < 4.5 TSH > 4.5 HT (%)
Ipsi Contra Ipsi Contra
X 6 12 67
X X 6 9 60
X X 4 19 83
X X X 4 2 33
X X X 3 7 70
X X X X 7 21 75123
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hypoparathyroidism immediately postoperative. This could
suggest vascular injury after hemithyroidectomy [14] or
after PTLN dissection. Therefore, it is advised to determine
serum calcium directly postoperatively frequently. Most
patients with hypoparathyroidism suVer also from hypothy-
roidism. Therefore, all patients with hypothyroidism should
be tested for hypothyroidism and the reverse.
In the present study almost all patients underwent at least
laryngectomy, hemithyroidectomy, radiotherapy together
with PTLN dissection. Therefore, it could be anticipated
that there is no clear additional risk of PTLN dissection for
the development of hypothyroidism. Moreover, we did not
Wnd an additional eVect of a bilateral PTLN dissection on
the development of hypothyroidism in the various treat-
ment groups.
In the present study age was the only signiWcant prog-
nostic factor for the development of hypothyroidism. It is
known that with aging more persons generally develop
hypothyroidism. In a previous study hemithyroidectomy
was one of the most important prognostic factors [4]. In the
present study all patients underwent hemithyroidectomy.
There are no general guidelines in performing a PTLN
dissection. Usually a PTLN dissection is performed in
advanced laryngeal and hypopharyngeal carcinomas with
subglottic involvement [8, 12]. It still remains to be identi-
Wed in which patients PTLN dissection is really indicated
[9]. Therefore, for clinical decision making and counseling
it is important to know that even bilateral PTLN dissection
does not contribute to the risk of development of hypothy-
roidism after treatment of laryngeal or hypopharyngeal
cancer.
In conclusion, the incidence of (para)hypothyroidism
after laryngectomy combined with hemithyroidectomy and
PTLN dissection is high. PTLN dissection can be per-
formed without additional risk of hypo(para)thyroidism.
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